A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries

BACKGROUND: A recently developed 10-valent pneumococcal non-typeable H influenzae protein D-conjugate vaccine (PHiD-CV) is expected to afford protection against more than two thirds of isolates causing IPD in children in Latin America, and also against acute otitis media caused by both Spn and NTHi....

Descripción completa

Detalles Bibliográficos
Autores principales: Martí, Sebastián García, Colantonio, Lisandro, Bardach, Ariel, Galante, Julieta, Lopez, Analía, Caporale, Joaquín, Knerer, Gerhart, Gomez, Jorge Alberto, Augustovski, Federico, Pichon-Riviere, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766226/
https://www.ncbi.nlm.nih.gov/pubmed/24004943
http://dx.doi.org/10.1186/1478-7547-11-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766226/
https://www.ncbi.nlm.nih.gov/pubmed/24004943
http://dx.doi.org/10.1186/1478-7547-11-21

Ejemplares similares